|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-11-12
|
|
pubmed:abstractText |
A two-compound product containing calcipotriol 50 microg/g and betamethasone dipropionate 0.5 mg/g (Daivobet, Dovobet) has been demonstrated to be an effective, once daily, treatment for psoriasis vulgaris.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1018-8665
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2004 S. Karger AG, Basel.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
209
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
308-13
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15539894-Administration, Topical,
pubmed-meshheading:15539894-Adolescent,
pubmed-meshheading:15539894-Adult,
pubmed-meshheading:15539894-Betamethasone,
pubmed-meshheading:15539894-Calcitriol,
pubmed-meshheading:15539894-Confidence Intervals,
pubmed-meshheading:15539894-Dihydroxycholecalciferols,
pubmed-meshheading:15539894-Dose-Response Relationship, Drug,
pubmed-meshheading:15539894-Double-Blind Method,
pubmed-meshheading:15539894-Drug Administration Schedule,
pubmed-meshheading:15539894-Drug Combinations,
pubmed-meshheading:15539894-Drug Therapy, Combination,
pubmed-meshheading:15539894-Female,
pubmed-meshheading:15539894-Follow-Up Studies,
pubmed-meshheading:15539894-Humans,
pubmed-meshheading:15539894-Male,
pubmed-meshheading:15539894-Middle Aged,
pubmed-meshheading:15539894-Odds Ratio,
pubmed-meshheading:15539894-Prospective Studies,
pubmed-meshheading:15539894-Psoriasis,
pubmed-meshheading:15539894-Reference Values,
pubmed-meshheading:15539894-Risk Assessment,
pubmed-meshheading:15539894-Severity of Illness Index,
pubmed-meshheading:15539894-Statistics, Nonparametric,
pubmed-meshheading:15539894-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial.
|
|
pubmed:affiliation |
Service de Dermatologie, Hôpital de l'Archet, Nice, France. Jean-Paul.Ortonne@unice.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
